China (Mainland)
Diamondsupplier 
99.5% up by Entecavir powder Entecavir API 142217-69-4 CAS NO.142217-69-4
- Min.Order: 25 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T
- Product Details
Keywords
- Entecavir
- Entecavir API
- Entecavir powder
Quick Details
- ProName: 99.5% up by Entecavir powder Entecavir...
- CasNo: 142217-69-4
- Molecular Formula: C12H15N5O3
- Appearance: White powder
- Application: anti-HIV, anti-HBV
- DeliveryTime: in 7 days after your payment
- PackAge: 1kg/bag ;25kg/drum
- Port: Shanghai/Beijing/Hangzhou
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.5% up
- Storage: Dry place
- Transportation: dry place
- LimitNum: 25 Kilogram
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Details
Hepatitis B virus (hepatitis B virus, HBV) infection is prevalent worldwide, but the prevalence of HBV infection varies greatly in different regions. Currently, there are 5 popular oral nucleoside (acid) analog drugs: Entecavir (ETV), Tenofovir (tenofovir, TDF), Telbivudine (LdT), Adefovir dipivoxil (adefovir, ADV), lamivudine (lamivudine, LAM). Entecavir is currently one of the first-line drugs for the antiviral treatment of patients with chronic hepatitis B recommended by the World Health Organization and national guidelines.
Entecavir, as a potent oral guanosine nucleoside analog, can selectively inhibit HBV replication. It can be phosphorylated into active triphosphates in cells and interacts with HBV reverse transcriptase natural substrate deoxyguanine triphosphate. Nucleoside competition produces drug effect. Compared with other nucleoside (acid) drugs, Entecavir has the characteristics of low incidence of resistance mutation, strongest antiviral effect and moderate price. To date, the database of the CFDA Drug Evaluation Center shows that there are more than 10 approved formulations of Entecavir.
